68740 Mrv0541 02231214392D 16 16 0 0 0 0 999 V2000 2.5741 -0.9212 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0 3.7010 -1.2232 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0 2.8760 0.2058 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.1135 -1.9376 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.4155 -0.8107 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.8596 -1.3337 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.1615 -0.2067 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.4189 -1.9984 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.4308 -1.7337 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.0030 0.7288 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 4.4155 1.9984 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.2885 -0.5087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.0030 -0.0962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3355 1.2138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.6705 1.2138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5905 1.9984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 6 1 0 0 0 0 1 7 1 0 0 0 0 1 9 2 0 0 0 0 1 12 1 0 0 0 0 2 4 1 0 0 0 0 2 5 1 0 0 0 0 2 8 2 0 0 0 0 2 12 1 0 0 0 0 3 12 1 0 0 0 0 10 13 1 0 0 0 0 10 14 1 0 0 0 0 10 15 1 0 0 0 0 11 15 2 0 0 0 0 11 16 1 0 0 0 0 12 13 1 0 0 0 0 14 16 2 0 0 0 0 M END > T3D2669 > t3db > OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O > InChI=1S/C5H10N2O7P2/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14) > XRASPMIURGNCCH-UHFFFAOYSA-N > C5H10N2O7P2 > 272.0896 > 271.996323708 > 8 > 20.097260908269067 > 1 > 5 > 0 > 0 > [1-hydroxy-2-(1H-imidazol-1-yl)-1-phosphonoethyl]phosphonic acid > -0.93 > -3.851108564002269 > -1.92 > 0 > 1 > -2 > 1.4203844443343967 > 0.6570370453814713 > 6.674963447469139 > 153.11 > 52.157700000000006 > 4 > 1 > 3.27e+00 g/l > zoledronate > 0 > T3D2669 > Zoledronate > 118072-93-8 > (1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid; (1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid; Aclasta; Reclast; ZOL; Zoledronic acid; Zometa; Zometa Concentrate > Organic Compound; Drug; Antihypocalcemic Agent; Bisphosphonate; Bone Density Conservation Agent; Antiresorptive; Metabolite; Synthetic Compound $$$$